biohack.The longevity wire
LIVE WIREUpdated · scanning every 6 hours
06:14 Menopause brings sudden body-wide changes, not a slow slide, study says✦06:17 Stem cell implants helped 9 Parkinson's patients move better, maker says✦05:42 Siblings born deaf respond to sounds after a newly approved gene therapy✦06:20 US gives up to $41M to test existing drugs for preventing Alzheimer's✦06:18 80-year-old's blood cells become brain stem cells that test under age 20✦05:46 Pill meant to help older dogs live longer is one FDA step from approval✦12:01 A daily pill for male hair loss passed its second big trial, maker says✦05:56 US gynecologists now back hormone therapy as first choice for hot flashes✦06:14 Menopause brings sudden body-wide changes, not a slow slide, study says✦06:17 Stem cell implants helped 9 Parkinson's patients move better, maker says✦05:42 Siblings born deaf respond to sounds after a newly approved gene therapy✦06:20 US gives up to $41M to test existing drugs for preventing Alzheimer's✦06:18 80-year-old's blood cells become brain stem cells that test under age 20✦05:46 Pill meant to help older dogs live longer is one FDA step from approval✦12:01 A daily pill for male hair loss passed its second big trial, maker says✦05:56 US gynecologists now back hormone therapy as first choice for hot flashes
← All story threadsSTORY THREAD

Drugs that lower Lp(a), an inherited heart risk.

1 report so far. New developments are added to this thread as they happen.

  1. Sep 4, 2026
    BIG TRIAL MISSES ITS MAIN GOAL, NOVARTIS SAYSCompany results · 8,323 people

    Drug lowered an inherited heart risk but missed its main goal, maker says

    Novartis says its monthly shot lowered Lp(a), an inherited fat particle in the blood, but did not reduce a combined count of serious heart problems in 8,323 people.